Trial Profile
Effect of esomeprazole [Nexium] on the pharmacokinetics of BMS-275183 [oral taxane] in patients with advanced malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2007
Price :
$35
*
At a glance
- Drugs BMS 275183 (Primary) ; Esomeprazole
- Indications Cancer; Gastrointestinal disorders
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 03 Jul 2007 New trial record.